Class 2 medicine recallHigh riskMedicine · 7 Apr 2020
Pharmaswiss Česka republika s.r.o. (an affiliate of Bausch & Lomb UK Limited) is recalling all unexpired batches of Emerade 300 microgram auto-injectors (also referred to as pens) from patients due to an error in…
Class 2 medicine recallHigh riskMedicine · 18 Mar 2020
Gedeon Richter (UK) Ltd is recalling all unexpired stock of Esmya 5 mg tablets from patients, pharmacies and wholesalers following a new case of liver failure requiring liver transplant in a patient taking the…
Class 2 medicine recallHigh riskMedicine · 4 Mar 2020
Pharmaswiss Česka republika s.r.o. (an affiliate of Bausch & Lomb UK Limited) is recalling all unexpired batches of Emerade 150 microgram auto-injectors (also referred to as pens) from patients due to an error in…
Class 2 medicine recallHigh riskMedicine · 2 Mar 2020
AOP Orphan Pharmaceuticals AG is recalling all unexpired stock of a batch of Tetrabenazine 25 mg tablets (from pharmacies and wholesalers) as a precautionary measure due to out of specification results for the assay,…
Class 2 medicine recallHigh riskMedicine · 13 Feb 2020
Accord-UK Limited is recalling all unexpired stock of Gliclazide 40 mg Tablets (Northstar Livery) from pharmacies and wholesalers as a precautionary measure due to out of specification results for dissolution, obtained during routine stability…
Class 2 medicine recallHigh riskMedicine · 3 Feb 2020
Medreich Plc is recalling all unexpired stock of the above products from pharmacies and wholesalers as a precautionary measure due to possible contamination with an impurity N-nitrosodimethylamine (NDMA) which has genotoxic and carcinogenic potential.
Class 2 medicine recallHigh riskMedicine · 30 Jan 2020
Wockhardt UK Ltd is recalling specific batches of Levothyroxine 100micrograms/5ml Oral Solution from pharmacies and wholesalers as a precautionary measure due to notification of the impurity liothyronine exceeding the specification limit.
Class 2 medicine recallHigh riskMedicine · 23 Jan 2020
LEO Laboratories Ltd (T/A LEO Pharma) is recalling all unexpired stock of the above products from pharmacies and wholesalers as a precautionary measure due to concerns on the possible risk of skin malignancy.
Class 2 medicine recallHigh riskMedicine · 16 Dec 2019
Medley Pharma Limited is recalling all unexpired stock of the below products from pharmacies and retail stores as a precautionary measure.
Class 2 medicine recallHigh riskMedicine · 5 Dec 2019
Accord Healthcare are recalling all unexpired stock of the below products from pharmacies and retail stores as a precautionary measure.
Class 2 medicine recallHigh riskMedicine · 28 Nov 2019
Pharmaswiss Česka republika s.r.o. (an affiliate of Bausch & Lomb UK Limited) is recalling all unexpired batches of Emerede Adrenaline Autoinjectors after identifying an error than can cause some pens to fail to activate.
Class 2 medicine recallHigh riskMedicine · 27 Nov 2019
M&A Pharmachem Limited is recalling all unexpired batches as a precautionary measure, because a small number of pots from some batches have been found to contain discoloured tablets due to fungal contamination.
Class 2 medicine recallHigh riskMedicine · 21 Nov 2019
OTC Concepts Ltd, Relonchem Ltd, Noumed Life Sciences Ltd and Medreich Plc. are recalling stock from pharmacies and retail stores as a precautionary measure due to possible contamination with an impurity.
Class 2 medicine recallHigh riskMedicine · 18 Nov 2019
Creo Pharma Limited and Tillomed Laboratories Limited are recalling all unexpired stock of the products listed in this alert.
Class 2 medicine recallHigh riskMedicine · 11 Nov 2019
Sandoz Limited is recalling one batch due to the occurrence of degradation in some vials, resulting in green discoloration of the powder in the vial, leading to increased levels of impurities/degradation products in the…
Class 2 medicine recallHigh riskMedicine · 7 Nov 2019
This recall affects Mitomycin-C Kyowa 2 mg (PL 16508/0042), 10 mg (PL 16508/0043), 20 mg (PL 16508/0044), powder for solution for injection, and Mitomycin-C Kyowa 40 mg (PL 16508/0045), powder for intravesical solution.
Class 2 medicine recallHigh riskMedicine · 5 Nov 2019
M & A Pharmachem is recalling specific batches as a precautionary measure, because a small number of pots from some batches have been found to contain discoloured tablets due to fungal contamination
Class 2 medicine recallHigh riskMedicine · 30 Oct 2019
B Braun is initiating a recall of certain batches of the above products as a precautionary measure. This is because ongoing product monitoring has identified that some bags may not comply with the required…
Class 2 medicine recallHigh riskMedicine · 25 Oct 2019
Omega Pharma Limited and Galpharm International Limited are recalling unexpired stock from pharmacies and retail stores as a precautionary measure due to possible contamination with an impurity.
Class 2 medicine recallHigh riskMedicine · 25 Oct 2019
Rosemont Pharmaceuticals Limited is recalling unexpired stock from pharmacies as a precautionary measure due to possible contamination with an impurity.
Class 2 medicine recallHigh riskMedicine · 23 Oct 2019
Pfizer Ltd is recalling certain batches of Sayana Press for subcutaneous injection.
Class 2 medicine recallHigh riskMedicine · 17 Oct 2019
Teva UK Limited trading as ratiopharm GmbH is recalling all unexpired stock of Ranitidine Effervescent Tablets from pharmacies.
Class 2 medicine recallHigh riskMedicine · 8 Oct 2019
GlaxoSmithKline, trading as Glaxo Welcome Ltd, is recalling all unexpired stock of Zantac (ranitidine hydrochloride) prescription only medicines (POM) from pharmacies.
Class 2 medicine recallHigh riskMedicine · 23 Sep 2019
Martindale Pharmaceuticals Limited is recalling the above batch due to an issue with homogeneity.